These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5783591)

  • 21. Irreversible enzyme inhibitors. CXIX. Active-site-directed irreversible inhibitors of dihydrofolic reductase with tissue specificity derived from 2,4,6-triaminopyrimidine with a terminal sulfonyl fluoride at the 5 position.
    Baker BR; Meyer RB
    J Med Chem; 1968 May; 11(3):489-94. PubMed ID: 5241408
    [No Abstract]   [Full Text] [Related]  

  • 22. Irreversible enzyme inhibitors. 113. Proteolytic enzymes. 3. Active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides with an N-fluorosulfonylphenyl substituent.
    Baker BR; Hurlbut JA
    J Med Chem; 1968 Mar; 11(2):233-41. PubMed ID: 5654208
    [No Abstract]   [Full Text] [Related]  

  • 23. Irrevesible enzyme inhibitors. CLI. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenylbutyl)-2,4-diaminopyrimidines with a terminal sulfonyl fluoride.
    Baker BR; Meyer RB
    J Med Chem; 1969 Mar; 12(2):224-7. PubMed ID: 5254099
    [No Abstract]   [Full Text] [Related]  

  • 24. Synthesis of fused [1,2,6]thiadiazine 1,1-dioxides as potential transition-state analogue inhibitors of xanthine oxidase and guanase.
    Meyer RB; Skibo EB
    J Med Chem; 1979 Aug; 22(8):944-8. PubMed ID: 490539
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irreversible enzyme inhibitors. CXII. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine substituted with a terminal sulfonyl fluoride. II.
    Baker BR; Lourens GJ
    J Med Chem; 1968 Jan; 11(1):38-41. PubMed ID: 5237173
    [No Abstract]   [Full Text] [Related]  

  • 26. Specific irreversible enzyme inhibitors.
    Baker BR
    Annu Rev Pharmacol; 1970; 10():35-50. PubMed ID: 4986559
    [No Abstract]   [Full Text] [Related]  

  • 27. Irreversible enzyme inhibitors. 184. An affinity column for purification of rat liver guanine deaminase and xanthine oxidase.
    Baker BR; Siebeneick HU
    J Med Chem; 1971 Sep; 14(9):799-801. PubMed ID: 5140006
    [No Abstract]   [Full Text] [Related]  

  • 28. 9-Benzoyl 9-deazaguanines as potent xanthine oxidase inhibitors.
    Rodrigues MV; Barbosa AF; da Silva JF; dos Santos DA; Vanzolini KL; de Moraes MC; Corrêa AG; Cass QB
    Bioorg Med Chem; 2016 Jan; 24(2):226-31. PubMed ID: 26712096
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Xanthine oxidase inhibition: effect of an N-alkyl substituent on C-2 of the nucleus of 8-azahypoxanthine.
    Biagi G; Giorgi I; Livi O; Scartoni V; Lucacchini A
    Farmaco; 1989 Sep; 44(9):843-9. PubMed ID: 2604836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Irreversible enzyme inhibitors. XCV. 8-(m-bromoacetamidobenzylthio)hypoxanthine, an active-site-directed irreversible inhibitor of xanthine oxidase.
    Baker BR; Kozma J
    J Med Chem; 1967 Jul; 10(4):682-5. PubMed ID: 6068312
    [No Abstract]   [Full Text] [Related]  

  • 31. Potent xanthine oxidase inhibitors--4(or 5)-diazoimidazole-5(or 4)-carboxamide and two related compounds.
    Iwata H; Yamamoto I; Muraki K
    Biochem Pharmacol; 1969 Apr; 18(4):955-7. PubMed ID: 5788540
    [No Abstract]   [Full Text] [Related]  

  • 32. On the mechanism of inactivation of xanthine oxidase by cyanide.
    Massey V; Edmondson D
    J Biol Chem; 1970 Dec; 245(24):6595-8. PubMed ID: 5536559
    [No Abstract]   [Full Text] [Related]  

  • 33. Isomeric N-methyl-7-deazaguanines: synthesis, structural assignment, and inhibitory activity on xanthine oxidase.
    Seela F; Bussmann W; Götze A; Rosemeyer H
    J Med Chem; 1984 Aug; 27(8):981-5. PubMed ID: 6547745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Irreversible enzyme inhibitors. 202. Candidate active-site-directed irreversible inhibitors of 5-fluoro-2'-deoxyuridine phosphorylase from Walker 256 rat tumor derived from 1-benzyl-5-(3-ethoxybenzyl)uracil.
    Kelley JL; Baker BR
    J Med Chem; 1982 May; 25(5):600-3. PubMed ID: 6211547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation analysis of Baker's studies on enzyme inhibition. 1. Guanine deaminase, xanthine oxidase, dihydrofolate reductase, and complement.
    Silipo C; Hansch C
    J Med Chem; 1976 Jan; 19(1):62-71. PubMed ID: 1246055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The regulation of xanthine oxidase. Inhibition by reduced nicotinamide-adenine dinucleotide of rat liver xanthine oxidase type D and of chick liver xanthine dehydrogenase.
    Della Corte E; Stirpe F
    Biochem J; 1970 Mar; 117(1):97-100. PubMed ID: 4316091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oxidation of 7-methylguanine by human xanthine oxidase.
    Skupp S; Ayvazian JH
    J Lab Clin Med; 1969 Jun; 73(6):909-16. PubMed ID: 5815015
    [No Abstract]   [Full Text] [Related]  

  • 38. [Reaction of fluorescein bimercuric acetate with a molybdenum center of xanthine oxidase from milk].
    Kozachenko AI; Nagler LG; Lependina OL; Ianovskaia IM; Vartanian LS
    Biokhimiia; 1987 Dec; 52(12):1948-57. PubMed ID: 2833934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Selective inhibition of xanthine oxidase by substituted pyridopyrimidines.
    Kaur S; Raman K; Pandey BR; Barthwal JP; Kishor K; Kumar A; Bhargava KP; Ali B
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):103-13. PubMed ID: 684270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and Biological Evaluation of Novel Aryl-2H-pyrazole Derivatives as Potent Non-purine Xanthine Oxidase Inhibitors.
    Sun ZG; Zhou XJ; Zhu ML; Ding WZ; Li Z; Zhu HL
    Chem Pharm Bull (Tokyo); 2015; 63(8):603-7. PubMed ID: 26040271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.